← Oncology Approval Tracker

FDA DECISION ·

Bosutinib 400 mg tablets

bosutinib monohydrate · MSN Laboratories

First generic approvalFirst genericChronic myeloid leukemia
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Final generic approval of the 400 mg Bosulif tablet. Labeled uses include chronic-phase Philadelphia chromosome-positive CML in adults and children age 1 or older who are newly diagnosed or resistant or intolerant to prior therapy, and accelerated- or blast-phase CML in resistant or intolerant adults.

LAMPGEN ANALYSIS

Why it matters

FDA approved generic 100 and 500 mg tablets under another application in 2025. This action added a finally approved 400 mg tablet for the labeled CML uses.

What research teams should watch

Distinguish tablet strengths and applicable FDA application actions. Verify product availability and document the phase of CML and prior-treatment response.

PRIMARY RECORDS

Sources